Uganda Confirms Two New Ebola Cases Amid Ongoing Outbreak

On Monday, May 25, 2026, Uganda's health ministry officially confirmed two additional cases of Ebola, elevating the total number of confirmed infections in the country to seven. These latest cases involve Ugandan healthcare professionals working at a private medical facility situated in the capital city, Kampala. Both individuals have been admitted to a dedicated treatment unit and are currently receiving care, as stated by Dr. Charles Olaro, the national director of health services. This recent surge in cases is directly linked to an ongoing Ebola outbreak in the neighboring Democratic Republic of Congo (DRC), which appears to have commenced several days or weeks prior to Congolese authorities formally declaring it on May 15, 2026. The index case in Uganda was identified as a 59-year-old Congolese man who was admitted to a hospital in Kampala on May 11, 2026, and tragically succumbed to the virus three days later, before his Ebola infection was confirmed. Subsequently, two other Congolese nationals seeking medical attention in Uganda also tested positive for Ebola. The initial local infections in Uganda were confirmed on Saturday, May 23, 2026, involving a driver and a health worker who had been exposed to the deceased Congolese patient. The two new cases confirmed on Monday, May 25, 2026, further highlight the spread within the healthcare community. In response to the escalating situation, Ugandan President Yoweri Museveni has advised citizens to refrain from shaking hands as a precautionary measure against infection. He also mandated the postponement of an annual religious gathering that typically draws thousands of pilgrims, including many from Congo, to a Catholic basilica near Kampala by June 3. Additional preventative measures include the temporary cessation of all public transportation and flights between Congo and Uganda. The World Health Organization (WHO) declared the Ebola outbreak in the Democratic Republic of Congo and Uganda a Public Health Emergency of International Concern (PHEIC) on May 17, 2026, underscoring the high risk of further transmission and the potential for the outbreak to be more extensive than currently reported. The particular strain of the virus responsible for this outbreak is the Bundibugyo ebolavirus (BDBV). A significant concern is that there is currently no licensed vaccine or specific therapeutic treatment available for this specific species of Ebola virus. Research into promising Bundibugyo vaccine candidates is in preclinical or early development, with estimates suggesting at least six more months are needed to produce sufficient doses for even a small clinical trial. In the Democratic Republic of Congo, suspected Ebola cases have reportedly surpassed 900, predominantly concentrated in the eastern Ituri province, which serves as the epicenter of the current outbreak. The response efforts in Congo have faced considerable challenges, including public fear, anger, and frustration, leading to attacks on treatment centers and a pervasive distrust of authorities in a region long plagued by armed conflict. For audiences in India, the Ministry of Health has stepped up preparedness measures, including enhanced airport surveillance, quarantine readiness, and laboratory capabilities, though officials emphasize that the immediate risk to India remains minimal. Furthermore, India has issued an advisory cautioning against non-essential travel to Congo, Uganda, and South Sudan due to the ongoing Ebola outbreak. This demonstrates a proactive approach to global health threats, recognizing the interconnectedness of international travel and public health. Previous Ebola outbreaks in Uganda, such as the one caused by the Sudan ebolavirus from September 2022 to January 2023, were successfully contained through robust governmental responses and international collaboration. That outbreak resulted in 164 cases and 55 confirmed deaths. However, the current situation with the Bundibugyo strain presents unique challenges due to the absence of approved vaccines and therapeutics. The international community, including WHO and various partners, is actively working with Ugandan health authorities to manage the crisis, but the lack of specific medical interventions for the Bundibugyo strain makes this a particularly urgent and complex public health challenge. The focus remains on rapid contact tracing, isolation of suspected cases, and community engagement to mitigate further spread.

Frequently Asked Questions

Read Full Story on Quick Digest